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Postoperative nausea and vomiting frequently complicate outpatient anesthesia
and surgery. The duration of treatment for this complication must occasionally
extend beyond discharge from the hospital. In this study, we evaluated the com-
monly used anti-emetic promethazine for its efficacy in the post-discharge
period.
Adult outpatient surgical patients who had excessive postoperative nausea and
vomiting in the recovery room, orwho were atriskforpostoperative nausea and
vomiting following discharge were given two promethazine suppositories (25
mg) for home use. All patients were contacted by our recovery room nurses on
the first business day after their surgery and questioned as to their use of the
suppositories and, ifused, their efficacy.
We found that 55 percent ofpatients givenpromethazine suppositories forhome
use had nausea and vomiting in the post-discharge period. Ofthe patients given
promethazine, 89 percent used the suppositories. All of these patients reported
improvement in their symptoms following use of the suppositories. None
reported adverse effects from the promethazine suppositories.
In conclusion, we found promethazine suppositories to be an inexpensive and
efficacious treatment for nausea and vomiting in adult outpatient surgical
patients following discharge from the hospital. Side-effects were minimal, and
our patients voiced no complaints about this mode of therapy. We recommend
this therapy for treatment of nausea and vomiting after hospital discharge fol-
lowing adult outpatient surgery.
INTRODUCTION
Postoperative nausea and vomiting (PONV)b are among the most common complica-
tions following outpatient anesthesia and surgery. They seldom result in admission to the
hospital, but they frequently delay discharge from the recovery room [1, 2]. The etiology
of PONV is multifactorial, and no single anesthetic technique changes its incidence sub-
stantially [2]. While PONV occurs most frequently in the immediate postoperative peri-
od, many patients develop PONV in thepost-anesthetic care unit (PACU) afterremoval of
theirintravenous (IV) line, ontheirwayhome orathome many hours post-operatively [3].
PONV that persists beyond discharge from the PACU occurs more frequently in patients
aTo whom all correspondence should be addressed: W. Brooks Gentry, M.D., University
of Arkansas for Medical Sciences, Department of Anesthesiology, 4301 W. Markham,
Slot 515, Little Rock, AR 72205. Tel.: 501-686-7611; Fax: 501-603-1951; E-mail: gentry-
wiliamb@exchange.uams.edu.
bAbbreviations: PONV, postoperative nausea and vomiting; IV, intravenous; PACU, post-anesthetic
careunit; UAMS ODS, University ofArkansas forMedical Sciences One-Day Surgery Center;ASA
PS, American Society of Anesthesiologists Physical Status; MAC, monitored anesthesia care; 5-
HT3, serotonin; H, orH2, histamine 1 or 2 receptors; D2, dopamine; I.M., intramuscular.
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who have had multiple episodes ofemesis in the PACU and in patients who have a histo-
ry ofmotion sickness. In addition, many patients with nohistory ofmotion sickness devel-
op nausea during their drive home, especially if they had middle ear surgery, pelvic
laparoscopy, inguinal herniorraphy or strabismus surgery [4, 5]. Finally, nausea and vom-
iting that occur at home negatively impact the outpatient surgery experience of patients
[6]. Treatment ofPONV must, therefore, frequently extend beyond the PACU stay ofour
patients.
Promethazine suppositories (Phenergan, Wyeth Laboratories, Philadelphia, PA; 25
mg in adults) are used frequently to treat PONV after patients are discharged from the
PACU [2]. Avoiding the oral route of administration decreases the possibility that emesis
will curtail its effectiveness, and therectal route avoids the necessity ofan IV line. In addi-
tion, promethazine suppositories have a long record of safe and effective use in the treat-
ment of PONV [7]. One or two promethazine suppositories are frequently prescribed for
outpatients by their surgeon orby thedischarging anesthesiologist at ourinstitution to take
home because PONV is usually short-lived, and this prescription usually treats PONV
effectively. We had not, however, evaluated the efficacy of this practice systematically.
Therefore, the first purpose ofour study was to determine the frequency ofpromethazine
suppository prescription to outpatients discharged from the University of Arkansas for
Medical Sciences One-Day Surgery Center (UAMS ODS). We then wanted to assess the
usage of promethazine dispensed to outpatients in the UAMS ODS PACU. Finally, we
wanted to evaluate the efficacy ofpromethazine suppositories in ameliorating nausea and
vomiting in adult outpatients following their discharge from the hospital.
METHODS
All ofthis study was performed and all data were collected following approval ofthe
UAMS Human ResearchAdvisory Committee. This study was an extension of a continu-
ous quality controlprotocol initiatedin ourPACU.Anypatientwho hadoutpatient surgery
in the 1997 calendar year and was given promethazine suppositories in the recovery room
to take home was enrolled retrospectively in this quality control study. We identified our
patients by medical record number only to avoid using the same patient twice.
Specific criteria forpromethazine prescription varied with each surgeon or anesthesi-
ologist; however, patients who developed PONV after removal of their intravenous line,
orhad aprolonged PACU stay due to PONV, orwhohad totake along cartrip to gethome
were given two promethazine suppositories (25 mg each) to take home along with instruc-
tions for their use. The nature and potential for side-effects were also discussed with the
patients. In addition, patients for whom their surgeons had written prophylactic promet-
hazineprescriptions were also included in the study group. Patientdemographics (age, sex
and weight), American Society ofAnesthesiologists Physical Status (ASA PS), anesthet-
ic regimens (general, monitored anesthesia care (MAC) or spinal) and the use ofany peri-
operative antiemetics were recorded on the day of surgery prior to discharge from the
PACU. Drugs that were classified as antiemetics included any agent that has been report-
ed to block serotonin (5-HT3), histamine (H1 orH2), muscarinic, ordopamine (D2) recep-
tors in the chemoreceptor trigger zone [3]. Drugs that were included were atropine,
ondansetron, nizatidine, ranitidine, famotidine, metoclopramide, promethazine ordroperi-
dol, and could have been administered from the time ofadmission to ODS to the time of
PACU discharge.
Standard follow-up for every patient who undergoes outpatient surgery in the ODS
center is a telephone call on the next business day by a nurse in the ODS PACU to evalu-
ate the patient for postoperative complications. On the day after surgery, the incidence of
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PONV in the time from PACU discharge until the time ofthe phone call, and the use and
efficacy of the promethazine treatment were recorded. To measure efficacy, the patients
were given a choice of the following responses to the promethazine treatment: no
improvement with suppository use, some improvement with suppository use, great
improvement with suppository use or worsening of symptoms with promethazine use.
We reviewed retrospectively the medical records of the patients for whom data was
collected during the quality control study for accuracy ofthe data collection. Specifically,
we reviewed the anesthesia patient preoperative evaluation, the anesthetic record and the
recovery room record to obtain this information. Patients who were nauseated after dis-
charge were compared with those who were not using chi-square contingency tables for
differences in sex, ASA PS, anesthetic regimens, perioperative use ofnarcotics and peri-
operative use ofantiemetics. Results are reported as mean ± SD.
RESULTS
A total of 108 patients were discharged fromtheUAMS ODS withpromethazine sup-
positories in 1997. The medical records ofnine ofthese were either unavailable or incom-
plete, and were excluded from the analysis. Demographic makeup and the surgical proce-
dures represented are shown in Tables 1 and 2, respectively.
The study group included 80 general anesthetics, 18 MAC anesthetics, and one spinal
anesthetic (Figure 1). In the study group, 54 of the 99 (55 percent) patients experienced
nausea after discharge. Ofthese 54 patients, 48 used the suppository (89 percent). Fifteen
of the nauseated patients in our study group had emesis, and of these, 10 used the sup-
pository. All ofthe 48 patients who used the suppository reported improvement of symp-
toms. Four ofthe 48 patients (eight percent) reported some improvement, and 44 patients
(92 percent) reported great improvement.
When assessing the patients who were nauseated after discharge vs. those who were
not, there were no differences in the proportions ofASA PS 1 toASA PS 2 patients, in the
proportions of males to females, in narcotic use or in the anesthetic type used in the two
groups. The use of antiemetics in the perioperative period in both groups was compared,
and we found that, of the patients who experienced nausea after discharge, 45 of 54 had
received an antiemetic in their perioperative course. Of the patients who did not experi-
ence nausea after discharge, 38 of45 had received an antiemetic. These proportions were
not significantly different.
Table 1: Demographic makeup ofthe study groups. Number ofmale and female patients are
shown, along with the number ofpatients in eachASA PS class.
Age (yrs): 47.3 ± 17.8
Sex (M/F) 39/60
ASA PS (1/2/3) 34/58/7
Table 2: Breakdown of the surgical procedures represented in the study group. Number of
patients undergoing each type ofsurgery is shown.
Bone marrow harvest 4 Orthopedic 29
Nose and throat 9 Otology 35
General surgery 1 Plastic surgery 9
Gynecology 1 Urology 4
Opthalmology 3
393Wright et al.: Promethazine suppositories in outpatients
100
Nauseatedl
I. 75I r 1 1 = Total u75
cu
Z 50
E 25
z
0
General MAC Spinal
Figure 1. Numbers of patients undergoing each type of anesthesia (general, spinal, or moni-
tored anesthesia care (MAC)) in the study group. The number of patients in each type of anes-
thetic who were nauseated after discharge is shown in the black portion ofeach column. The pro-
portion ofnauseated patients who underwent general anesthesia was not different from that under-
going MAC anesthesia.
DISCUSSION
According to UAMS records (Division of Surgical Services, University ofArkansas
for Medical Sciences), 2719 patients had outpatient surgery at our ODS center in 1997.
The frequency ofpromethazine suppository prescriptions written to the outpatients in our
hospital in 1997 was, therefore, 108/2719, or about 4 percent. Ifwe assume that our over-
all incidence of PONV after discharge is not different from the observations of other
authors (about 7 percent [1]), we identified and treated over halfof our patients who suf-
fered PONV after discharge from the hospital.
In this study, we found that promethazine suppositories are effective in treating
PONV at home following outpatient surgery, and that a high percentage of patients who
sufferedPONV usedthepromethazine suppositories. The nauseaofall ofthepatients who
took the suppositories improved. While promethazine and other phenothiazines have a
long history of successful use as antiemetics [8], and their effects on the chemoreceptor
trigger zone are well documented [9], other reasons forimprovement must be considered.
A placebo effect could have contributed to the improvement. Also, because nausea and
vomiting after surgery tend to be short-lived, they are most likely to attenuate and abate
shortly after completion ofthe procedure. Finally, the administration ofantiemetics in the
perioperative period could have improved the condition of these patients. Comparison of
our study group to a placebo group could help answer these questions, but this was not
done in this study because ofethical considerations.
Promethazine suppositories were well-tolerated in our patients, with no reports of
adverse effects. Excess sedation, which is a well-known side effect of the phenothiazines
[10] in particular, was not reported as a problem. Other potential neurologic side-effects
include acute dystonia, akathisia, Parkinsonism, neuroleptic malignant syndrome, perioral
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tremor and tardive dyskinesia, but long-term exposure is usually necessary for develop-
ment of most of these complications [9]. Anticholinergic effects are also reported as fre-
quentproblems afterpromethazine use [9]. However, the anticholinergic effects ofpromet-
hazine may be beneficial in patients who must travel great distances after surgery because
this action contributes to its effectiveness as an antimotion sickness drug [11]. Ourpatients
noted neither neurologic nor anticholinergic effects.
Another advantage ofpromethazine is that it is acost-effective measure for treatment
ofPONV. The outpatient patient charge at our hospital pharmacy is $1.85 per 25 mg sup-
pository (University ofArkansas for Medical Sciences, Inpatient Satellite Pharmacy). We
compared this to an intramuscular (IM) injection of ephedrine (25 mg)/hydroxyzine (25
mg). This is another treatment that has been commonly used in our patients who have
PONV after removal of their IV line. The patient cost of one administration of IM
ephedrine/hydroxyzine is $22.35 (University ofArkansas for Medical Sciences Inpatient
Satellite Pharmacy). The patient charge for one dose ofondansetron (4 mg) IV is $111.05
(University ofArkansas for Medical Sciences, Inpatient Satellite Pharmacy). One hour of
outpatient recovery time in our hospital costs $476.40 (Division of Surgical Services,
University ofArkansas for Medical Sciences). Therefore we consider promethazine sup-
positories a very cost-effective way to treat patients with PONV.
In conclusion, we have identified promethazine suppositories as a safe and effective
regimen for treatment ofPONV following discharge ofour adult outpatients. Overhalfof
our outpatients likely to experience PONV after discharge were given the prescription.
Nearly 90 percent of the patients who had PONV after discharge used the prescription,
with marked improvement of symptoms. In addition, this use ofpromethazine supposito-
ries appears to be safe, as there were no reported side-effects. Finally, promethazine sup-
positories are a cost-effective treatment in our hospital.
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